ライフサイエンスコーパス: behavioral symptom

1 on FC-signatures exhibit worse cognitive and behavioral symptoms.

2 bolic biological dysregulations and specific behavioral symptoms.

3 isease may lead to recovery of cognitive and behavioral symptoms.

4 ptake inhibitors (SSRIs) in treating certain behavioral symptoms.

5 rhaps before the first clinically noticeable behavioral symptoms.

6 changes in CSF and plasma MT, CSF MHPG, and behavioral symptoms.

7 months, heterozygous female mice also showed behavioral symptoms.

8 dents with AD who exhibited psychotic and/or behavioral symptoms.

9 rrelates the timing of these events with the behavioral symptoms.

10 sociation of ischemic lesions to distinctive behavioral symptoms.

11 characterized by heterogeneous cognitive and behavioral symptoms.

12 ms and an overall worsening of cognitive and behavioral symptoms.

13 neuronal structural deficits and reversal of behavioral symptoms.

14 een determined as a score of 1 or higher and behavioral symptoms.

15 argely ignore biological factors in favor of behavioral symptoms.

16 d with a range of neurological, somatic, and behavioral symptoms.

17 working memory impairment and development of behavioral symptoms.

18 n heterogeneity may underpin this variety of behavioral symptoms.

19 me as well as neural correlates of cognitive-behavioral symptoms.

20 report prominent neurological, medical, and behavioral symptoms.

21 significant clinical importance in terms of behavioral symptoms.

22 bnormalities can also treat neurological and behavioral symptoms.

23 suring the severity of several affective and behavioral symptoms.

24 Fmr1 KO mice may also ameliorate autism-like behavioral symptoms.

25 approximately correlating with the onset of behavioral symptoms.

26 therapies to ameliorate core amygdala-based behavioral symptoms.

27 ine for 4weeks from birth can alleviate some behavioral symptoms.

28 tism spectrum disorder prior to emergence of behavioral symptoms.

29 n (i.e., c-Fos expression) coincide with the behavioral symptoms.

30 related to the development of early autistic behavioral symptoms.

31 rhythms, providing a mechanistic link to the behavioral symptoms.

32 or deterioration that preceded cognitive and behavioral symptoms (7 [21.9%] vs 6 [1.7%]).

33 ence, 0.01; 95% CI, -0.01 to 0.03; P = .19), behavioral symptoms (agitated or reactive behavior adjus

34 Behavioral symptoms also coincided with altered expressi

35 ription drug fill patterns for cognitive and behavioral symptoms among patients with Alzheimer diseas

36 Roadway runoff experimentally triggers behavioral symptoms and associated changes in blood indi

37 The relationship between AD behavioral symptoms and asymmetry in spatial tau PET pat

38 soluble and insoluble forms of Abeta to the behavioral symptoms and biochemical consequences of the

39 intervention or usual care regarding patient behavioral symptoms and caregiver strain.

40 romises an unbiased framework to investigate behavioral symptoms and causative genetic factors.

41 address the neural circuitry underlying the behavioral symptoms and comorbidities, the cell types pl

42 ed on an actual case, we characterize common behavioral symptoms and describe a strategy for selectin

43 ility changes correlated with intestinal and behavioral symptoms and health-related quality of life o

44 ocial and pharmacologic therapies may reduce behavioral symptoms and improve quality of life for pati

45 neurobiological conditions with overlapping behavioral symptoms and of unknown etiologies.

46 ventions aimed at preventing or ameliorating behavioral symptoms and optimizing developmental outcome

47 Surprisingly, both the onset of home-cage behavioral symptoms and pathological alterations occurre

48 institution was evaluated by comparing their behavioral symptoms and performance on cognitive measure

49 a care had significant effects on decreasing behavioral symptoms and psychotropic medication use in d

50 Conclusion: The association between behavioral symptoms and reduced prefrontal CB(1)R levels

51 Behavioral symptoms and semantic dementia were associate

52 t the biological mechanisms underlying these behavioral symptoms and their relationship to the diseas

53 ce as evidence emerges of sex differences in behavioral symptoms and treatment response in neuropsych

54 range, 0-176; higher scores indicate greater behavioral symptoms), and functional (Total Functional C

55 n a CBA x C57BL/6 background and show robust behavioral symptoms, and HD knock-in (KI) mice, which ha

56 ted ADHD symptoms, co-occurring emotional or behavioral symptoms, and interpersonal functioning.

57 escribed that precedes the onset of clinical behavioral symptoms, and is brief and age-delimited to t

58 ority of executive function tests, increased behavioral symptoms, and left prefrontal cortex atrophy

59 ce unique challenges due to its early onset, behavioral symptoms, and slow progression of decline.

60 olved in many of the observed anatomical and behavioral symptoms, and that the further analysis of th

61 Many psychiatric conditions present complex behavioral symptoms, and the type and magnitude of under

62 Behavioral symptoms are a common adverse effect of breas

63 ies to address the devastating cognitive and behavioral symptoms are also urgently needed.

64 sociated with diverse neurodevelopmental and behavioral symptoms as well as obesity.

65 owever, their combination resulted in severe behavioral symptoms, as well as spontaneous recurrent co

66 ansmission to the amygdala may contribute to behavioral symptoms associated with depression.

67 Here we use adult zebrafish to study behavioral symptoms associated with drug-evoked seizures

68 ell-being and to reduce or slow emergence of behavioral symptoms associated with low purpose.

69 rstanding and treatment of the cognitive and behavioral symptoms associated with neurological disorde

70 use embryonic stem cells exhibit none of the behavioral symptoms associated with the Lesch-Nyhan synd

71 re 2-6 or persisting chorea, psychiatric, or behavioral symptoms at final follow-up after >=6 months;

72 ale score 0-1 and no chorea, psychiatric, or behavioral symptoms at final follow-up).

73 disorder characterized by variable motor and behavioral symptoms attributed to major neuropathology o

74 ased significantly in transgenics when overt behavioral symptoms began (5-7 weeks) and was most prono

75 rescribed to people with dementia to address behavioral symptoms but can also cause harm in this popu

76 d deficits in social cognition and low-level behavioral symptoms, but not communication-related sympt

77 strategy that facilitates early treatment of behavioral symptoms by identifying underlying causes and

78 rons could be a useful strategy for treating behavioral symptoms caused by PE.

79 9]; P < .001) and a trend toward less severe behavioral symptoms compared with bvFTD (SMD, -0.22 [95%

80 rats significantly ameliorated parkinsonian behavioral symptoms compared with controls (vehicle, sin

81 income supplements, prevalence of adolescent behavioral symptoms decreased significantly.

82 l impairments that predispose the patient to behavioral symptoms, destroy intellectual capacity and p

83 The biological mechanisms underlying behavioral symptom development are poorly understood.

84 ch decrement could contribute to some of the behavioral symptoms displayed by AD patients.

85 Physical and behavioral symptoms displayed by Ndufs4(fky/fky) mice in

86 in function in the first year of life, overt behavioral symptoms do not emerge until the second year.

87 ortex has been extensively linked to several behavioral symptom domains related to anxiety disorders,

88 o-basal ganglia circuits underlying discrete behavioral symptom domains relevant to these complex dis

89 ould explain the increased vulnerability for behavioral symptoms during early childhood.

90 Subthreshold behavioral symptoms (e.g., cognitive deficits and substa

91 treatment of affected individuals before any behavioral symptoms emerge.

92 included measures of cognitive function and behavioral symptoms from nursing home assessments, indic

93 Psychiatric and behavioral symptoms, functioning, cognition, care needs,

94 These behavioral symptoms impair quality-of-life and are often

95 Aggressive behavior is a frequent behavioral symptom in Alzheimer's disease.

96 ntation strategy was able to rescue abnormal behavioral symptoms in a pre-clinical model of psychiatr

97 rove cognition and treat psychosis and other behavioral symptoms in Alzheimer's disease, Parkinson's

98 ches to manipulate new neurons show that the behavioral symptoms in animal models of neuropsychiatric

99 This study confirms high rates of behavioral symptoms in breast cancer survivors, particul

100 l route to improve gastrointestinal (GI) and behavioral symptoms in children with ASD, and fecal micr

101 diet may increase the risk of emotional and behavioral symptoms in children.

102 Importance: Emotional and behavioral symptoms in cognitively normal older people m

103 quinone toxicity and link vascular injury to behavioral symptoms in coho salmon.

104 Nonpharmacologic management of behavioral symptoms in dementia can significantly improv

105 The late afternoon/evening exacerbation of behavioral symptoms in dementia has been recognized by c

106 Systematic screening for behavioral symptoms in dementia is an important preventi

107 n replicate a broad spectrum of parkinsonian behavioral symptoms in Drosophila that are associated wi

108 tial probiotic therapy for GI and particular behavioral symptoms in human neurodevelopmental disorder

109 es, peripheral and central inflammation, and behavioral symptoms in mice.

110 This may contribute to behavioral symptoms in NBIA and hemochromatosis and is r

111 f atypical antipsychotics on psychiatric and behavioral symptoms in patients with Alzheimer's disease

112 Psychosocial interventions may reduce mild behavioral symptoms in patients with NDD, and pharmacoth

113 Clinical evidence suggests that mood and behavioral symptoms in premenstrual dysphoric disorder (

114 neuronal damage as early as day 10 (prior to behavioral symptoms) in all MOG-injected groups, ii) a s

115 Behavioral symptoms included hyperkinetic behavior (100%

116 Addiction is a disorder of behavioral symptoms including enhanced incentive salienc

117 All core behavioral symptoms, including disinhibition, apathy, lo

118 se of signs of abnormal developmental and/or behavioral symptoms, increasingly, individuals are prese

119 transtympanic administration of TTX produced behavioral symptoms indicative of transient vestibular d

120 sticity are responsible for the long-lasting behavioral symptoms induced by this form of stress.

121 erogeneity of underlying neural networks and behavioral symptoms is essential.

122 Although striking behavioral symptoms may be present, care providers often

123 evelopmental delay, intellectual disability, behavioral symptoms, medical comorbidities, and dysmorph

124 y before the onset of clear neurological and behavioral symptoms, might prevent or ameliorate the dev

125 nts had measures of ADHD and other emotional/behavioral symptoms (N = 6933) and/or enough clinical da

126 Behavioral symptoms (neuropsychiatric symptoms and bvFTD

127 Alongside behavioral symptoms, neuropsychiatric symptoms were very

128 opsychiatric diseases and are among the many behavioral symptoms not amenable to pharmacological inte

129 d stress disorders are based on ameliorating behavioral symptoms, not on reversing the synaptic patho

130 hesized to underwrite multiple cognitive and behavioral symptoms observed in many neurological disord

131 of the biochemical, neurophysiological, and behavioral symptoms observed in the fragile X mouse.

132 and mitophagy, and was able to alleviate the behavioral symptoms observed in zebrafish and mouse mode

133 s a neuropsychiatric syndrome with motor and behavioral symptoms occurring in patients with or withou

134 The behavioral symptoms of AD correlate with the accumulatio

135 stics seen in SHRs that seem to parallel the behavioral symptoms of ADHD are not solely due to hypera

136 owning" is the occurrence or exacerbation of behavioral symptoms of Alzheimer's disease in the aftern

137 trates disease-related phenotypes, including behavioral symptoms of ASD and epilepsy.

138 caused by these individual mutations to core behavioral symptoms of ASD remain poorly understood.

139 one of the neural mechanisms underlying the behavioral symptoms of ASD, we determined the correlatio

140 ative to the group curve are associated with behavioral symptoms of ASD.

141 c connectivity correlated significantly with behavioral symptoms of ASD.

142 <.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).

143 and brain circuits associated with the core behavioral symptoms of autism.

144 rior to supportive psychotherapy in reducing behavioral symptoms of bulimia nervosa (binge eating and

145 The use of antipsychotics to treat the behavioral symptoms of dementia is associated with great

146 ntrast to 100% of the MOG+Vehicle group with behavioral symptoms of EAE, 63% and 68% of the MOG+OGF a

147 th staff members, showed significantly fewer behavioral symptoms of emotional distress than orphans w

148 networks that may underlie the cognitive and behavioral symptoms of FXS.

149 The mortality rate and the behavioral symptoms of hypertensive encephalopathy decre

150 Y1-INs are necessary and sufficient for the behavioral symptoms of neuropathic pain and represent a

151 Our results indicate that the behavioral symptoms of neuropathic pain states can be tr

152 I) score during pregnancy with emotional and behavioral symptoms of offspring at 7 to 10 years of age

153 is specifically manifest after the onset of behavioral symptoms of prion disease.

154 la abnormalities contribute to emotional and behavioral symptoms of psychopathy.

155 Many neural and behavioral symptoms of Rett syndrome may result from dys

156 To the ill patient with diabetes, the behavioral symptoms of sickness such as fatigue and apat

157 an animal model that closely mimics the key behavioral symptoms of social anxiety disorder (SAD).

158 n barrier (BBB) and blood-gill barrier cause behavioral symptoms of urban runoff mortality syndrome i

159 nic receptor antagonist mecamylamine induced behavioral symptoms of withdrawal measured as increased

160 pidly shifting emotional, interpersonal, and behavioral symptoms, often co-morbid with mood and anxie

161 sed risk of all three analyzed emotional and behavioral symptoms: OR 1.07, 95% CI, 1.03-1.11; OR 1.07

162 tympanic administration of 3 mM TTX produced behavioral symptoms paralleling those previously reporte

163 d the highest frequency and severity of most behavioral symptoms, particularly disinhibition (79.3%-1

164 factors (fear, anxious-misery, psychosis and behavioral symptoms) plus a general factor: overall psyc

165 of 4 stages of thiamine deficiency based on behavioral symptoms: pre-symptomatic stage, ataxic stage

166 Behavioral symptoms preceded neuropathological anomalies

167 ular and synaptic alterations underlying the behavioral symptoms present in neurodevelopmental disord

168 of habit circuit white matter tracts and AN behavioral symptoms provides support for a circuit based

169 ing somatic, cognitive, and psychological or behavioral symptoms, referred to as persistent postconcu

170 egulations map more consistently to atypical behavioral symptoms reflecting altered energy intake/exp

171 Addiction manifests as physiologic and behavioral symptoms related to a maladaptive pattern of

172 use ablation of mGluR7 leads to a variety of behavioral symptoms related to PFC dysfunction, such as

173 tal PM(2.5) exposure on neurodevelopment and behavioral symptoms, respectively.

174 For global behavioral symptom scores associated with dementia in el

175 at the severe end of a spectrum of cognitive-behavioral symptoms seen in childhood epilepsies, and th

176 ementia (range, 0-36; higher scores, greater behavioral symptoms severity; minimal clinically importa

177 to the NMDA receptor (NMDAR) and results in behavioral symptoms similar to those obtained with model

178 Behavioral symptoms such as aggression were frequently a

179 GNIFICANCE STATEMENT Dementia and associated behavioral symptoms such as memory loss and sleep distur

180 Behavioral symptoms such as repetitive speech, wandering

181 and F-actin loss and recapitulated the core behavioral symptoms, such as deficits in social interact

182 e constellation of post-injury cognitive and behavioral symptoms suggest permanent effects of injury

183 aptic plasticity in the VP mediates opposing behavioral symptoms; targeting the VP may provide novel

184 Cases with bvAD showed more severe behavioral symptoms than tAD (standardized mean differen

185 le attention has been given to an additional behavioral symptom that BED shares with SUDs-sleep dysre

186 vant traits that are more tractable than the behavioral symptoms that classify mental illness.

187 ess and neuropsychiatric brain disorder with behavioral symptoms that include hallucinations, delusio

188 Although primarily defined in terms of behavioral symptoms, the global neurophysiological effec

189 e assessed for the presence of cognitive and behavioral symptoms using a battery of neuropsychologic

190 acy endpoint was the change from baseline in behavioral symptoms using the Anxiety Depression and Moo

191 left dorsolateral prefrontal cortex, whereas behavioral symptoms were associated with hypoactivation

192 The behavioral symptoms were evaluated with the Swanson, Nol

193 Behavioral symptoms were evident as early as 15 min post

194 Mood and behavioral symptoms were monitored with daily self-ratin

195 Teacher-rated behavioral symptoms were used to categorize children fro

196 This peptide does not elicit gross behavioral symptoms when injected centrally or periphera

197 wed a unique sex difference in showing these behavioral symptoms, which is reminiscent of human condi

198 tended to have more autonomic complaints and behavioral symptoms while the severe- ME/CFS group had h

199 tended to have more autonomic complaints and behavioral symptoms while the severe-ME/CFS group had hi

200 were assessed for presence of cognitive and behavioral symptoms with a battery of neuropsychological

201 ays showed a significant global worsening of behavioral symptoms with short-term tryptophan depletion

202 HIV) are at increased risk for emotional and behavioral symptoms, yet few studies have examined relat